GE Healthcare looks to self-manufacture imaging agent Optison

01/16/2013 | Pharmaceutical Business Review Online

GE Healthcare is seeking approval to independently manufacture Optison, a contrast agent for cardiac imaging. The company has submitted a supplemental new drug application for the agent to U.S. regulators. "While we cannot predict a timeline for regulatory authority approval, we look forward to servicing the U.S. cardiology community directly in 2013," said GE Healthcare's Stephen Lightfoot.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT